Further analysis of Caucasian patients with ER-positive breast cancer suggested that the patients with poor overall survival (Group 2) have significantly less progesterone receptor expression (odds ratio = 3.682, P < 0.0001). The gene discussed is PGR; the disease is breast carcinoma.